[2602.21648] Multimodal Survival Modeling and Fairness-Aware Clinical Machine Learning for 5-Year Breast Cancer Risk Prediction

[2602.21648] Multimodal Survival Modeling and Fairness-Aware Clinical Machine Learning for 5-Year Breast Cancer Risk Prediction

arXiv - Machine Learning 4 min read Article

Summary

This article presents a multimodal machine learning framework for predicting 5-year breast cancer survival, integrating clinical and genomic data to improve model calibration and fairness.

Why It Matters

Accurate breast cancer risk prediction is crucial for effective treatment planning. This study addresses common pitfalls in clinical risk models, such as poor calibration and subgroup disparities, by introducing a robust framework that emphasizes fairness and reproducibility, potentially improving patient outcomes.

Key Takeaways

  • Introduces a multimodal framework for breast cancer survival prediction.
  • Compares CoxNet and XGBoost models for performance and fairness.
  • Achieves high accuracy with AUCs of 98.3 and 98.6 for CoxNet and XGBoost, respectively.
  • Emphasizes the importance of fairness auditing across diverse patient demographics.
  • Provides a reproducible approach that can be applied to other clinical datasets.

Computer Science > Machine Learning arXiv:2602.21648 (cs) [Submitted on 25 Feb 2026] Title:Multimodal Survival Modeling and Fairness-Aware Clinical Machine Learning for 5-Year Breast Cancer Risk Prediction Authors:Toktam Khatibi View a PDF of the paper titled Multimodal Survival Modeling and Fairness-Aware Clinical Machine Learning for 5-Year Breast Cancer Risk Prediction, by Toktam Khatibi View PDF Abstract:Clinical risk prediction models often underperform in real-world settings due to poor calibration, limited transportability, and subgroup disparities. These challenges are amplified in high-dimensional multimodal cancer datasets characterized by complex feature interactions and a p >> n structure. We present a fully reproducible multimodal machine learning framework for 5-year overall survival prediction in breast cancer, integrating clinical variables with high-dimensional transcriptomic and copy-number alteration (CNA) features from the METABRIC cohort. After variance- and sparsity-based filtering and dimensionality reduction, models were trained using stratified train/validation/test splits with validation-based hyperparameter tuning. Two survival approaches were compared: an elastic-net regularized Cox model (CoxNet) and a gradient-boosted survival tree model implemented using XGBoost. CoxNet provides embedded feature selection and stable estimation, whereas XGBoost captures nonlinear effects and higher-order interactions. Performance was assessed using time-depend...

Related Articles

Yupp shuts down after raising $33M from a16z crypto's Chris Dixon | TechCrunch
Machine Learning

Yupp shuts down after raising $33M from a16z crypto's Chris Dixon | TechCrunch

Less than a year after launching, with checks from some of the biggest names in Silicon Valley, crowdsourced AI model feedback startup Yu...

TechCrunch - AI · 4 min ·
Machine Learning

[R] Fine-tuning services report

If you have some data and want to train or run a small custom model but don't have powerful enough hardware for training, fine-tuning ser...

Reddit - Machine Learning · 1 min ·
Machine Learning

[D] Does ML have a "bible"/reference textbook at the Intermediate/Advanced level?

Hello, everyone! This is my first time posting here and I apologise if the question is, perhaps, a bit too basic for this sub-reddit. A b...

Reddit - Machine Learning · 1 min ·
Machine Learning

[D] ICML 2026 review policy debate: 100 responses suggest Policy B may score higher, while Policy A shows higher confidence

A week ago I made a thread asking whether ICML 2026’s review policy might have affected review outcomes, especially whether Policy A pape...

Reddit - Machine Learning · 1 min ·
More in Machine Learning: This Week Guide Trending

No comments

No comments yet. Be the first to comment!

Stay updated with AI News

Get the latest news, tools, and insights delivered to your inbox.

Daily or weekly digest • Unsubscribe anytime